Vaccine and antiviral drug promise for preventing post-acute sequelae of COVID-19, and their combination for its treatment
T Sumi, K Harada - Frontiers in Immunology, 2024 - frontiersin.org
Introduction Most healthy individuals recover from acute SARS-CoV-2 infection, whereas a
remarkable number continues to suffer from unexplained symptoms, known as Long COVID …
remarkable number continues to suffer from unexplained symptoms, known as Long COVID …
[PDF][PDF] Global properties of delayed models for SARS-CoV-2 infection mediated by ACE2 receptor with humoral immunity
AM Elaiw, AS Alsulami, AD Hobiny - AIMS Mathematics, 2024 - aimspress.com
The coronavirus disease 2019 (COVID-19) is caused by a new coronavirus known as
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 infects the …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 infects the …
Global Stability of a Delayed Model for the Interaction of SARS-CoV-2/ACE2 and Adaptive Immunity
AM Elaiw, AS Alsulami, AD Hobiny - International Journal of Analysis …, 2024 - etamaths.com
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the culprit
behind the coronavirus disease 2019 (COVID-19), which has killed millions of people. SARS …
behind the coronavirus disease 2019 (COVID-19), which has killed millions of people. SARS …
[PDF][PDF] Effect of ACE2 receptor and CTL response on within-host dynamics of SARS-CoV-2 infection
AM Elaiwa, AS Alsulamia, AD Hobinya - 2024 - researchgate.net
Since the end of 2019, scientists and researchers have intensified their efforts to
comprehend the within-host dynamics of the severe acute respiratory syndrome coronavirus …
comprehend the within-host dynamics of the severe acute respiratory syndrome coronavirus …